Innovative global solutions through science, engineering, and technology.
Financial Corp.
Publicly-traded on the OTCQB under the symbol “DFCO”, Dalrada Financial Corp. and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. The team is dedicated to scaling and accelerating business growth through exceptional financial planning, risk and business analysis, advanced technology platforms, branding, sales and marketing, human resources, legal, accounting, and administrative support.
DALRADA
Precision
DALRADA
DALRADA
Health Products
Publicly-traded on the OTCQB under the symbol “DFCO”, Dalrada Financial Corp. and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. The team is dedicated to scaling and accelerating business growth through exceptional financial planning, risk and business analysis, advanced technology platforms, branding, sales and marketing, human resources, legal, accounting, and administrative support.
DALRADA
Precision
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that due to the growing need for precision medicine worldwide, the Company is entering the global genomics market with the launch of Dalrada Health’s product portfolio, Empower Genomics.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that, effective immediately, Mr. David Pickett has accepted the position of Dalrada’s Executive Vice President of Sales and Business Development.
To provide aid during natural disasters and for everyday use cost savings, LikidoVOLT® innovates commercial and residential sustainable, independent clean power generation resulting in low carbon emissions.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Mr. Tom Giles was appointed to Dalrada’s Board of Directors.
SAN DIEGO, CA – FEBRUARY 16, 2021 – Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) reported its financial results for three months ended September 30, 2020.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Mr. Anthony Zolezzi has accepted an appointment to Dalrada’s Board of Directors.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that due to the growing need for precision medicine worldwide, the Company is entering the global genomics market with the launch of Dalrada Health’s product portfolio, Empower Genomics.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that, effective immediately, Mr. David Pickett has accepted the position of Dalrada’s Executive Vice President of Sales and Business Development.
To provide aid during natural disasters and for everyday use cost savings, LikidoVOLT® innovates commercial and residential sustainable, independent clean power generation resulting in low carbon emissions.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Mr. Tom Giles was appointed to Dalrada’s Board of Directors.
Innovative global solutions through science, engineering, and technology.
Financial Corp.
Publicly-traded on the OTCQB under the symbol “DFCO”, Dalrada Financial Corp. and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. The team is dedicated to scaling and accelerating business growth through exceptional financial planning, risk and business analysis, advanced technology platforms, branding, sales and marketing, human resources, legal, accounting, and administrative support.
DALRADA
Precision
DALRADA
DALRADA
Health Products
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that due to the growing need for precision medicine worldwide, the Company is entering the global genomics market with the launch of Dalrada Health’s product portfolio, Empower Genomics.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that, effective immediately, Mr. David Pickett has accepted the position of Dalrada’s Executive Vice President of Sales and Business Development.
To provide aid during natural disasters and for everyday use cost savings, LikidoVOLT® innovates commercial and residential sustainable, independent clean power generation resulting in low carbon emissions.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Mr. Tom Giles was appointed to Dalrada’s Board of Directors.
SAN DIEGO, CA – FEBRUARY 16, 2021 – Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) reported its financial results for three months ended September 30, 2020.
Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Mr. Anthony Zolezzi has accepted an appointment to Dalrada’s Board of Directors.
